cl 77891 titanium dioxide factories
At our manufacturing facility, we are committed to sustainability and environmental responsibility. We take great care to ensure that our production processes are as environmentally friendly as possible, and we are constantly looking for ways to reduce our carbon footprint. By choosing our nano titanium dioxide products, customers can be confident that they are supporting a company that is dedicated to preserving the planet for future generations.
At our company, we are constantly investing in research and development to innovate and improve our product offerings. We are committed to staying at the forefront of technological advancements in the pigment industry to ensure that we continue to meet the evolving needs of our customers.
A safety review conducted by the EFSA in 2021 assessed thousands of studies published on titanium dioxide.
Skin irritation
In addition to its advanced manufacturing processes, c1 77891 factory also focuses on sustainability and environmental responsibility
On November 23, 2022, the General Court of the European Union reversed the conclusion that titanium dioxide was carcinogenic and released a statement (1,2):
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”